Trailing-twelve-month (TTM) revenue is $492.02 Million with a year-over-year growth of +6.77%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $128,339,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $123,807,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-10 |
| Q1 FY2026Period ended 2026-03-31 | $122,892,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $116,985,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $492,023,000 |
Current P/S: $220,514,282 market capitalization ÷ $492,023,000 TTM revenue = 0.45x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $116.98M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:52:27.443Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Personal Care Products | N/A | N/A | N/A | N/A | $18M | $23M |
| Shipping and Handling | $3M | $2M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| JAPAN | N/A | N/A | N/A | N/A | N/A | $56M |
| KOREA, REPUBLIC OF | $62M | $61M |
$492.02M
$492.02 Million
+6.77%
vs. $460.83M a year ago (TTM)
+3.54%
5 Year compound annual growth rate
1 Year
+6.77%
3 Year
+4.40%
5 Year
+3.54%
10 Year
+4.03%
15 Year
+2.09%
20 Year
+1.63%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $480.14M | +$25.78M | +5.67% |
| 2024 | $454.36M | +$9.04M | +2.03% |
| 2023 | $445.32M | +$23.41M | +5.55% |
| 2022 | $421.91M | ($22.17M) | (4.99%) |
| 2021 | $444.08M | +$58.88M | +15.29% |
| 2020 |
TTM Growth
+6.77%
3-Year CAGR
+4.40%
5-Year CAGR
+3.54%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T20:52:27.443Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1M |
| N/A |
| N/A |
| $50M |
| $51M |
| $51M |
| Other Countries | $188M | $245M | $196M | $204M | $204M | $173M |
|---|
| TAIWAN | N/A | N/A | $48M | $62M | $71M | $67M |
|---|
| UNITED STATES | $135M | $138M | $123M | $129M | $128M | $133M |
|---|
| $385.20M |
| +$22.99M |
| +6.35% |
| 2019 | $362.21M | ($2.60M) | (0.71%) |
| 2018 | $364.81M | +$22.78M | +6.66% |
| 2017 | $342.03M | +$870,000 | +0.26% |
| 2016 | $341.16M | +$16.45M | +5.07% |
